Enterococcus: Difference between revisions

From IDWiki
Enterococcus
()
m (Text replacement - " species}}" to "")
Line 44: Line 44:
*[[Is treated by::Daptomycin]], [[Is treated by::doxycycline]], [[Is treated by::linezolid]], [[Is treated by::tedizolid]], [[Is treated by::oritavancin]], [[Is treated by::quinupristin-dalfopristin]] (for ''E. faecium'')
*[[Is treated by::Daptomycin]], [[Is treated by::doxycycline]], [[Is treated by::linezolid]], [[Is treated by::tedizolid]], [[Is treated by::oritavancin]], [[Is treated by::quinupristin-dalfopristin]] (for ''E. faecium'')


{{DISPLAYTITLE:''Enterococcus'' species}}
{{DISPLAYTITLE:''Enterococcus''
[[Category:Gram-positive cocci]]
[[Category:Gram-positive cocci]]

Revision as of 08:36, 9 February 2022

Background

Microbiology

  • Genus of facultative anaerobic, non-spore-forming, alpha- or gamma-hemolytic, catalase negative, Gram-positive cocci
  • Grows on bile esculin agar
  • PYR positive
  • Most are Lancefield group D
  • Commensal gut flora
  • Increasing antibiotic resistance

Species

  • E. faecalis
    • More common (90-95%)
    • More commonly genitourinary source
    • More susceptible to antibiotics
  • E. faecium
    • Less common (5-10%)
    • More commonly gastrointestinal source
    • Less susceptible to antibiotics
    • Most common VRE
  • E. gallinarum
  • E. casseliflavus
  • E. hirae, a rare zoonotic pathogen from chickens that can cause bacteremia and endocarditis

Vancomycin Resistance

  • Vancomycin binds to d-Ala-d-Ala pentapeptids, interfering with cell wall synthesis
  • VanA: most common. Mutation to d-Ala-d-Lac, leading to high resistance to glycopeptides.
  • VanB: more common in E. faecium in Australia
  • VanC: chromosomal resistance on E. gallinarum and E. casseliflavus

Management

VRE

{{DISPLAYTITLE:Enterococcus